| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/02/2002 | EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 10/02/2002 | EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| 10/02/2002 | EP1244614A2 Tryptase inhibitors |
| 10/02/2002 | EP1244498A2 Combination of trimebutine with an opioid analgesic |
| 10/02/2002 | EP1244472A2 Particulate vitamin composition |
| 10/02/2002 | EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 10/02/2002 | EP1244466A2 Activation and inhibition of the immune system |
| 10/02/2002 | EP1244461A2 INHIBITION OF GSK-3$g(b) |
| 10/02/2002 | EP1244460A1 Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
| 10/02/2002 | EP1244459A2 Treatment of drug-resistant human immunodeficiency virus infection |
| 10/02/2002 | EP1244458A2 Weight promoting composition, method, and product |
| 10/02/2002 | EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 10/02/2002 | EP1244456A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 10/02/2002 | EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 10/02/2002 | EP1244454A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 10/02/2002 | EP1244453A1 Method and composition for the treatment of pain |
| 10/02/2002 | EP1244452A1 Urotensin-ii receptor antagonists |
| 10/02/2002 | EP1244451A1 Substituted piperazine and piperidine calcium channel blockers |
| 10/02/2002 | EP1244450A1 8-aza-bicyclo[3.2.1]octane nmda/nr2b antagonists |
| 10/02/2002 | EP1244449A1 Use of ketotifen as ophthalmic agent |
| 10/02/2002 | EP1244448A2 Novel methods for the treatment and prevention of ileus |
| 10/02/2002 | EP1244447A2 Novel methods and compositions involving opioids and antagonists thereof |
| 10/02/2002 | EP1244446A1 Thrombopoietin mimetics |
| 10/02/2002 | EP1244445A2 Use of azoles for preventing skin cancer |
| 10/02/2002 | EP1244444A1 Process for formulation of carbapenem antibiotic compositions |
| 10/02/2002 | EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 10/02/2002 | EP1244442A1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |
| 10/02/2002 | EP1244441A1 Use of trimebutine for treating pain |
| 10/02/2002 | EP1244440A1 Agonists specific for the peripheral cannabinoid receptor |
| 10/02/2002 | EP1244439A1 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage |
| 10/02/2002 | EP1244438A1 Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina |
| 10/02/2002 | EP1244437A1 Tertiary amino compounds having opioid receptor affinity |
| 10/02/2002 | EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 10/02/2002 | EP1244435A2 POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES |
| 10/02/2002 | EP1244434A2 Use of chemotherapeutic agents |
| 10/02/2002 | EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 10/02/2002 | EP1244431A1 Transdermal administration of reboxetine |
| 10/02/2002 | EP1244427A2 Pharmaceutical compositions for oral administration |
| 10/02/2002 | EP1244426A1 Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer |
| 10/02/2002 | EP1244401A1 Drug delivery of phase changing formulation |
| 10/02/2002 | EP1244359A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 10/02/2002 | EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 10/02/2002 | EP1144459B1 Cross-linked hyaluronic acids and medical uses thereof |
| 10/02/2002 | EP1137660B1 22s-hydroxycholesta-8,14-diene derivatives with meiosis regulating activity |
| 10/02/2002 | EP1129091B1 Crf receptor antagonists and methods relating thereto |
| 10/02/2002 | EP1123103B1 A process for producing an iron-dextran compound |
| 10/02/2002 | EP1119321A4 Patient temperature regulation method and apparatus |
| 10/02/2002 | EP1100803B1 Pyrrolo [2,1-b] [1,3]benzothiazepines with atypical antipsychotic activity |
| 10/02/2002 | EP1098894B1 Fkbp inhibitors |
| 10/02/2002 | EP1098648B1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 10/02/2002 | EP1079840B1 Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer |
| 10/02/2002 | EP1077964B1 Fumagillol derivatives and processes for preparing the same |
| 10/02/2002 | EP1064009B1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 10/02/2002 | EP1047684B1 Substituted alpha,beta-anellated butyrolactones |
| 10/02/2002 | EP1047450B1 Ace inhibitor-mmp inhibitor combinations |
| 10/02/2002 | EP0996435B1 Amino acid derivatives useful to treat stroke |
| 10/02/2002 | EP0991414A4 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
| 10/02/2002 | EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds |
| 10/02/2002 | EP0984787B1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas |
| 10/02/2002 | EP0966285B1 Use of (+)mefloquine for the treatment of malaria |
| 10/02/2002 | EP0960107B1 6-thio-substituted paclitaxels |
| 10/02/2002 | EP0936915B1 Chelating agents and their metal chelates for treating free radicals induced conditions |
| 10/02/2002 | EP0928187A4 Antibacterial composition |
| 10/02/2002 | EP0923594B1 Bromotiacumicin compounds |
| 10/02/2002 | EP0906301B1 Benzofuryl derivatives and their use |
| 10/02/2002 | EP0906279B1 Pyrrole derivatives |
| 10/02/2002 | EP0896532B1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals |
| 10/02/2002 | EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 10/02/2002 | EP0853628B1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use |
| 10/02/2002 | EP0843675B1 Aza-anthracyclinone derivatives |
| 10/02/2002 | EP0842181B1 Membrane-permeant second messengers |
| 10/02/2002 | EP0841946B1 Methods for treatment of allergic asthma |
| 10/02/2002 | EP0841924B1 Benzimidazole compounds |
| 10/02/2002 | EP0840602B1 Use of a retinoid for preparing an antibacterial drug |
| 10/02/2002 | EP0839035B1 Antifungal agent, compound therefor, process for producing the same |
| 10/02/2002 | EP0817624B1 Inhibitors of metazoan parasite proteases |
| 10/02/2002 | EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia |
| 10/02/2002 | EP0788356B9 Method and compositions for inhibiting protein kinases |
| 10/02/2002 | EP0717750B1 Double-stranded peptide nucleic acids |
| 10/02/2002 | EP0715628B1 Substituted azaindolylidene compounds and process for their preparation |
| 10/02/2002 | EP0706521B1 Imides as tnf alpha inhibitors |
| 10/02/2002 | EP0698018B1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, their preparation and use |
| 10/02/2002 | EP0689534B1 Amide derivatives as 5-ht 1a? ligands |
| 10/02/2002 | EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 10/02/2002 | EP0651636B1 Chemotherapy for cancer |
| 10/02/2002 | DE10117185A1 Composition, useful for treating diabetes mellitus, comprises vegetable dietary fiber and alpha-glucosidase inhibitor administered in combination or immediately before or after |
| 10/02/2002 | DE10115945A1 Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 10/02/2002 | DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis |
| 10/02/2002 | DE10114762A1 Treatment of lung diseases, especially adult respiratory distress syndrome, by administration of cysteine protease inhibitor, especially calpain inhibitor |
| 10/02/2002 | DE10114364A1 Verfahren zur Herstellung von antibiotischen Kompositen A process for producing antibiotic composites |
| 10/02/2002 | DE10114245A1 Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung Preparation and Use of an antibiotic / antibiotics preparation |
| 10/02/2002 | DE10114244A1 Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung Antibiotic / antibiotics preparation with retarding active ingredient release |
| 10/02/2002 | DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility |
| 10/02/2002 | DE10113974A1 Reducing body weight and/or appetite, especially in therapy of obesity, using dihydrolipoic acid or derivative as stable, non-toxic anorectic agent |
| 10/02/2002 | DE10113513A1 Drug combination of kinase inhibitor and neurotropic factor, useful for treating and/or preventing nerve and/or glial cell damage, e.g. associated with neurodegenerative diseases |
| 10/02/2002 | DE10112926A1 Use of sugar phosphate or aminoacid having e.g. transaminase inhibiting activity, for treating tumors and/or sepsis or inducing immunosuppression |
| 10/02/2002 | DE10112925A1 Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren, Aminosäureanalogen zur Modulation von Transaminasen und/oder der Assoziation p36/Malat Dehydrogenase Use of sugar phosphates, sugar phosphate analogs, amino acids, amino acid analogues for the modulation of transaminases and / or association of p36 / malate dehydrogenase |
| 10/02/2002 | DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives |
| 10/02/2002 | DE10112325A1 Lagerstabile Fertiginfusionslösungen des Paracetamols Storage stable finished infusion solutions of paracetamol |
| 10/02/2002 | DE10111682A1 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use |